Across TCGA pan-cancer cohorts, ANKRD20A11P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ANKRD20A11P data layer compared with 23 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher ANKRD20A11P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ANKRD20A11P expression acts as an unfavorable survival marker.

READ, HNSC, and LGG are the cancer types where ANKRD20A11P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	All	0.166	0.830	<.001	30	view →
HNSC	DFS	Median	All	0.133	0.625	.040	6	view →
LGG	OS	Median	All	0.306	0.799	.009	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ANKRD20A11P tumor-vs-normal RNA expression · all ANKRD20A11P data types